Insurance-Based Disparities in Cardiac Allograft Vasculopathy After Heart Transplantation Are Mediated by Care at High-Volume Centers
Related Posts
Fu R, Meng D, Han X, Liu L, Chen C, Zheng R, Zhao Y, Zhang X, Lin X, Hasani M, Song Y, Liang T, Wen[...]
Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali[...]
Gajjar A, Raju AK, Gajjar A, Menon M, Shah SAY, Dani S, Weinberg A. SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome. Biomedicines. 2025[...]